Publications by authors named "Mario Pessoa"

Claim this Profile
L
Latin American association for the study of the liver (ALEH) guidance on postoperative care after liver transplantation.
Liana Codes, Rodrigo Zapata, Manuel Mendizabal, Alfeu de Medeiros Fleck Junior, Juan Carlos Restrepo, Mário Guimarães Pessoa

Ann Hepatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updated recommendations for the management of metabolic dysfunction-associated steatotic liver disease (MASLD) by the Latin American working group.
Luis Antonio Diaz, Juan Pablo Arab, Francisco Idalsoaga, Javiera Perelli, Javier Vega, Mario G Pessoa

Ann Hepatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Latin American association for the study of the liver (ALEH) guidance on preoperative care in liver transplantation: referral criteria, patient assessment, and waiting list management.
Victoria Mainardi, Josefina Pages, Josemaría Menendez, Rodrigo Zapata, Luis Antonio Díaz, Mário Guimarães Pessoa

Ann Hepatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term pioglitazone use in MASLD patients: insights from a multicentric preliminary study.
Isabel Veloso Alves Pereira, Ana Beatriz Souza de Oliveira, Patricia Momoyo Yoshimura Zitelli, Lais Arrivabene Barbieri, Ana Carolina Cardoso, Mário G Pessoa

Clinics (Sao Paulo)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of the PNPLA3 rs738406 C>G polymorphism on hepatocellular carcinoma risk in Brazilian patients with chronic hepatitis C and advanced fibrosis.
Claudia Maccali, Isabel Veloso Alves Pereira, Lisa Rodrigues da Cunha Saud, Regiane Saraiva de Souza Melo Alencar, Arthur Ivan Nobre Oliveira, Mario Guimarães Pessoa

Clinics (Sao Paulo)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PATTERNS OF ALCOHOL CONSUMPTION AND MENTAL HEALTH IN HCV-INFECTED PATIENTS: IMPLICATIONS FOR ANTIVIRAL ELIGIBILITY.
Lívia Beraldo de Lima, André Malbergier, Priscila Dib Gonçalves, Suzane Kioko Ono, Anderson Sousa Martins-DA-Silva, Mário Guimarães Pessoa

Arq Gastroenterol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of fibrosis, clinical events and mortality in MASLD: Data from the Global-MASLD study.
Zobair M Younossi, Leyla de Avila, Salvatore Petta, Hannes Hagström, Seung Up Kim, Mario Guimaraes Pessoa

Hepatology· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global Consensus Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis.
Zobair M Younossi, Shira Zelber-Sagi, Jeffrey V Lazarus, Vincent Wai-Sun Wong, Yusuf Yilmaz, Mário Guimarães Pessoa

Gastroenterology· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High inherited risk predicts age-associated increases in fibrosis in patients with MASLD.
Luis Antonio Díaz, William Alazawi, Saaket Agrawal, Juan Pablo Arab, Marco Arrese, Mario G Pessoa

J Hepatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global performance of non-invasive tests in MASLD: Insights from the G-MASLD study.
Zobair M Younossi, Leyla de Avila, Salvatore Petta, Hannes Hagström, Seung Up Kim, Mario Guimaraes Pessoa

Hepatology· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inherited Genetic Risk of Liver Fibrosis in Lean Versus Nonlean Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).
Kaleb Tesfai, Luis Antonio Díaz, Juan Pablo Arab, Marco Arrese, Francisco Idalsoaga, Mario G Pessoa

Aliment Pharmacol Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Projected Global Clinical, Humanistic, and Economic Impact of Metabolic Dysfunction-Associated Steatohepatitis (MASH): The Cost of Inaction Based on Data From Nine Countries.
Zobair M Younossi, James M Paik, Jeffrey V Lazarus, Patrizia Burra, Yuichiro Eguchi, Mário Guimarães Pessoa

Clin Gastroenterol Hepatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymorphism's MBOAT7 as Risk and MTARC1 as Protection for Liver Fibrosis in MASLD.
Sofia Rocha, Claudia P Oliveira, José Tadeu Stefano, Roberta P Yokogawa, Michele Gomes-Gouvea, Mario G Pessoa

Int J Mol Sci· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disparities in screening and risk stratification for Hispanic adults with metabolic dysfunction-associated steatotic liver disease.
Monica A Tincopa, Luis Antonio Díaz, Daniel Q Huang, Juan Pablo Arab, Marco Arrese, Mario G Pessoa

Hepatology· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increasing Treatment Uptake for Chronic Hepatitis B in South America: A Comparative Analysis of Country-Specific and WHO 2024 Guidelines.
Manuel Mendizabal, Constanza D Sabate, Esteban González Ballerga, Fernando Gruz, Ezequiel Ridruejo, Mario G Pessoa

J Viral Hepat· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alkaline phosphatase and liver fibrosis at diagnosis are associated with deep response to ursodeoxycholic acid in primary biliary cholangitis.
Guilherme Grossi Lopes Cançado, Patrícia da Silva Fucuta, Nathalia Mota de Faria Gomes, Cláudia Alves Couto, Eduardo Luiz Rachid Cançado

Clin Res Hepatol Gastroenterol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis A in Latin America: The current scenario.
Viviana E Ré, Ezequiel Ridruejo, Anabella C Fantilli, Bruna Damásio Moutinho, María Belén Pisano, Mário Guimarães Pessoa

Rev Med Virol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of Anti-Strongyloides Antibodies in the Serum of Liver Transplant Recipients: Need of Screening for This Neglected Helminthiasis.
Marcelo Andreetta Corral, Dirce Mary Correia Lima Meisel, Michele Soares Gomes Gouvêa, Mario Guimarães Pessoa, Edson Abdala

Parasite Immunol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASSOCIATION BETWEEN ANXIETY AND DEPRESSION IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD).
Eloyse Cristina Botacin, Sebastião Mauro Bezerra Duarte, José Tadeu Stefano, Mary Ellen Dias Barbosa, Mario Guimarães Pessoa

Arq Gastroenterol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new and simple score to predict adequate and deep response to ursodeoxycholic acid in patients with primary biliary cholangitis: the ALP-A score.
Guilherme Grossi Lopes Cançado, Nathalia Mota de Faria Gomes, Cláudia Alves Couto, Eduardo Luiz Rachid Cançado, Debora Raquel Benedita Terrabuio

Eur J Gastroenterol Hepatol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noninvasive assessment of liver fibrosis can predict clinical outcomes at late follow-up after a sustained virological response in HCV patients?
Taisa Grotta Ragazzo, Patricia Momoyo Yoshimura Zitelli, Daniel F Mazo, Claudia P Oliveira, Flait José Carrilho, Mário Guimarães Pessoa

Clinics (Sao Paulo)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2022 Clinical Practice Guideline.
Ahmed Arslan Yousuf Awan, Marina C Berenguer, Annette Bruchfeld, Fabrizio Fabrizi, David S Goldberg

Ann Intern Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uniting to defeat steatotic liver disease: A global mission to promote healthy livers and healthy lives.
Aleksander Krag, Maria Buti, Jeffrey V Lazarus, Alina M Allen, Jacqueline Bowman, Mário G Pessoa

J Hepatol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for cancer in patients with primary biliary cholangitis and autoimmune hepatitis and primary biliary cholangitis overlap syndrome.
Michelle Harriz Braga, Guilherme Grossi Lopes Cançado, Paulo Lisboa Bittencourt, Cláudia Alves Couto, Laura Vilar Guedes, Mario Guimarães Pessoa

Ann Hepatol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAZILIAN SOCIETY OF HEPATOLOGY UPDATED RECOMMENDATIONS FOR SYSTEMIC TREATMENT OF HEPATOCELLULAR CARCINOMA.
Aline Lopes Chagas, Cassia Regina Guedes Leal, Vivianne Barreto de Mello, Fábio Marinho Do Rego Barros, Paulo Lisboa Bittencourt, Mario Guimarães Pessoa

Arq Gastroenterol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis